Prostate Cancer News and Research

Latest Prostate Cancer News and Research

The ABC of terminal hemorrhage management

To best cope with terminal hemorrhage, at-risk patients should be identified by healthcare professionals while their families and caregivers are prepared, supported, and instructed to assure, be there for, and calm and comfort the patient as the event occurs, say researchers.

26 Sep 2012

Armband labeling could prevent DNR confusion

Implementation of an electronic ordering and armband labeling process for patients with Do Not Resuscitate orders improved correct documentation of their wishes as well as physicians’ ability to recognize and act on them during a cardiac arrest scenario, report US researchers.

25 Sep 2012

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers at Mayo Clinic's campus in Florida. Their recent study, published in the online edition of Psycho-Oncology, suggests that men who experience high levels of "cancer-specific anxiety" following surgery for prostate cancer could likely benefit from counseling designed to address their worries and improve their quality of life.

25 Sep 2012

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment, "active surveillance" has emerged as a plausible option, encouraged for men whose tumors may not need immediate treatment and may never progress to more serious illness. Appropriate criteria for selecting patients for active surveillance are continuously debated.

25 Sep 2012

Anti-androgen therapies may benefit bladder cancer patients

Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A University of Colorado Cancer Center study published today in the Proceedings of the National Academy of Sciences shows that CD24 expression may depend on androgens - and that anti-androgen therapies like those currently used to treat prostate cancer may benefit bladder cancer patients.

25 Sep 2012

Protect Your Manhood, ZERO collaborate to address prostate health

ZERO – The End of Prostate Cancer is partnering with Protect Your Manhood, a New Hampshire seacoast based start-up founded by prostatitis survivor and marketing maven Chris Sargent, which offers a culturally relevant resource to promote prostate health.

25 Sep 2012

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

ASTRO's Annual Meeting is the premier scientific meeting in radiation oncology and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world.

24 Sep 2012

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

On Aug. 8, Massachusetts' third health care cost control bill became law. It "sets annual state spending targets, encourages the formation of accountable care organizations, and establishes an independent commission to oversee health care system performance."

21 Sep 2012

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

Complete story behind connection between XMRV virus and prostate cancer

A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments - some dating back nearly a decade - has confirmed.

20 Sep 2012

APR-246 can restore function of defective p53 and activate apoptosis in cancer cells

The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells can acquire the ability to evade apoptosis and become more resistant to therapy.

20 Sep 2012

Alendronate decreases BMD loss in prostate cancer

Weekly administration of oral biphosphonate alendronate could reduce loss of bone mineral density in prostate cancer patients who start androgen-deprivation therapy, show study findings.

19 Sep 2012

US and Dutch views differ on sedation at end of life

Physicians from the USA and the Netherlands differ in their views on sedation at the end of life, with the Dutch justifying it by stating that it does not hasten death, and the Americans indicating that although it might hasten death, this is justifiable if it is not the primary intention, show study findings.

18 Sep 2012

Frontline teamwork, safety practices slice hospital infection rate by 40%

Implementation of the Comprehensive Unit-based Safety Program has reduced the rate of central line-associated bloodstream infections by 40% in more than 1100 US intensive care units, reports the agency that funded the program.

18 Sep 2012

Abiraterone acetate confirmed to offer significant survival benefit to advanced prostate cancer patients

Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).

18 Sep 2012

Power of taxane-based chemotherapy drugs may be potentially underestimated

The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.

18 Sep 2012

Philadelphia Eagles, TJUH partner to educate about prostate health and cancer awareness

September is Prostate Cancer Awareness month, and Thomas Jefferson University Hospitals has again teamed up with the Philadelphia Eagles to educate fans and others about prostate health and to raise cancer awareness.

18 Sep 2012

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

Aprea today announced positive data from a completed Phase I/II clinical study with its investigational drug APR-246. The results from the study have been published in the Journal of Clinical Oncology.

18 Sep 2012

Poll: 14% of Canadians believe women can be diagnosed with prostate cancer

According to a recent Leger Marketing poll, 14 per cent of Canadians believe women can be diagnosed with prostate cancer, and an additional 20 per cent aren't sure. Only 56 per cent know with certainty that men are the only ones who can be afflicted.

18 Sep 2012

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells.

14 Sep 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

The ABC of terminal hemorrhage management

Armband labeling could prevent DNR confusion

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

Anti-androgen therapies may benefit bladder cancer patients

Protect Your Manhood, ZERO collaborate to address prostate health

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

MD Anderson introduces Moon Shots Program to reduce cancer deaths

Complete story behind connection between XMRV virus and prostate cancer

APR-246 can restore function of defective p53 and activate apoptosis in cancer cells

Alendronate decreases BMD loss in prostate cancer

US and Dutch views differ on sedation at end of life

Frontline teamwork, safety practices slice hospital infection rate by 40%

Abiraterone acetate confirmed to offer significant survival benefit to advanced prostate cancer patients

Power of taxane-based chemotherapy drugs may be potentially underestimated

Philadelphia Eagles, TJUH partner to educate about prostate health and cancer awareness

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

Poll: 14% of Canadians believe women can be diagnosed with prostate cancer

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in